Dr Atmosukarto has over 15 years of experience in commercial R&D. She is the Chief Scientific Officer and Managing Director of Lipotek Pty Ltd, a niche biotech company which has its roots at the Australian National University. Lipotek holds patents and know-how in the use of liposomes as vaccine adjuvanting scaffolds and drug delivery vehicles. Dr Atmosukarto has been instrumental in securing funding from a wide range of sources including government, through Federal programs such as the Biotechnoloy Innovation Fund, Commercial Ready and Climate Ready programs, the ACT government (Trade Connect program), the Bill and Melinda Gates Foundation, the Global Connection Fund, private investors, and commercial collaborators.

She was the driving force behind the planning and execution of a First In Human (FIH) trial of a candidate vaccine for malignant melanoma. Under her leadership, Lipotek has established strong relationships with various stakeholders in Indonesia, including PT Bio Farma, LIPI, Eijkman Institute and UNPAD. Lipotek and Bio Farma are collaborating on the development of a novel vaccine for tuberculosis with the aim to initiate a clinical trial in the next 18 months. Since 2021, she is serving as a member of the advisory board of the Indonesian Health Institute, a centre of excellence established by the ministry of State-Owned Enterprise Healthcare Cluster. Dr Atmosukarto has driven collaborative research in the commercial and academic settings and, in the last 5 years, has actively been involved in the supervision of Honours students and PhD students at the John Curtin School of Medical Research. Since 2018 she is supporting the JCSMR Irradiation Immunity Interaction Laboratory with management of R&D.

Dr Atmosukarto holds a BSc, (First Class Honours) and PhD from the University of Adelaide. Her undergraduate and honours studies were made possible by the STAID scholarship program pioneered by Prof BJ Habibie and her PhD was funded through an IPRS and University of Adelaide scholarship. Upon completing her PhD, Dr Atmosukarto pioneered the establishment of a natural product screening facility at the Indonesian Institute of Sciences (LIPI) which led to the establishment of the natural product-based start-up company PT Indo Bio Pertiwi. She was the first Indonesian woman to secure the UNESCO-L’Oreal Fellowship in 2004 which helped drive a national program to improve the participation of women in science. For her contribution in promoting STEM, she was awarded the Anugerah IPTEK 2012 from the President of Indonesia.


Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: